List of Tables
Table 1. Global Gum Swelling and Pain Relief Medicine Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Gum Swelling and Pain Relief Medicine Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Gum Swelling and Pain Relief Medicine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Gum Swelling and Pain Relief Medicine Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Gum Swelling and Pain Relief Medicine Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Gum Swelling and Pain Relief Medicine Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Gum Swelling and Pain Relief Medicine Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Gum Swelling and Pain Relief Medicine by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gum Swelling and Pain Relief Medicine as of 2024)
Table 11. Global Gum Swelling and Pain Relief Medicine Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Gum Swelling and Pain Relief Medicine Companies Headquarters
Table 13. Global Gum Swelling and Pain Relief Medicine Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Gum Swelling and Pain Relief Medicine Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Gum Swelling and Pain Relief Medicine Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Gum Swelling and Pain Relief Medicine Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Gum Swelling and Pain Relief Medicine Revenue by Application (2026-2031) & (US$ Million)
Table 21. Gum Swelling and Pain Relief Medicine High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Gum Swelling and Pain Relief Medicine Growth Accelerators and Market Barriers
Table 25. North America Gum Swelling and Pain Relief Medicine Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Gum Swelling and Pain Relief Medicine Growth Accelerators and Market Barriers
Table 27. Europe Gum Swelling and Pain Relief Medicine Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Gum Swelling and Pain Relief Medicine Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Gum Swelling and Pain Relief Medicine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Gum Swelling and Pain Relief Medicine Investment Opportunities and Key Challenges
Table 31. Central and South America Gum Swelling and Pain Relief Medicine Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Gum Swelling and Pain Relief Medicine Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Gum Swelling and Pain Relief Medicine Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. OraPharma Corporation Information
Table 35. OraPharma Description and Major Businesses
Table 36. OraPharma Product Features and Attributes
Table 37. OraPharma Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. OraPharma Revenue Proportion by Product in 2024
Table 39. OraPharma Revenue Proportion by Application in 2024
Table 40. OraPharma Revenue Proportion by Geographic Area in 2024
Table 41. OraPharma Gum Swelling and Pain Relief Medicine SWOT Analysis
Table 42. OraPharma Recent Developments
Table 43. Sunstar Group Corporation Information
Table 44. Sunstar Group Description and Major Businesses
Table 45. Sunstar Group Product Features and Attributes
Table 46. Sunstar Group Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Sunstar Group Revenue Proportion by Product in 2024
Table 48. Sunstar Group Revenue Proportion by Application in 2024
Table 49. Sunstar Group Revenue Proportion by Geographic Area in 2024
Table 50. Sunstar Group Gum Swelling and Pain Relief Medicine SWOT Analysis
Table 51. Sunstar Group Recent Developments
Table 52. Hainan Jianke Pharmaceutical Corporation Information
Table 53. Hainan Jianke Pharmaceutical Description and Major Businesses
Table 54. Hainan Jianke Pharmaceutical Product Features and Attributes
Table 55. Hainan Jianke Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Hainan Jianke Pharmaceutical Revenue Proportion by Product in 2024
Table 57. Hainan Jianke Pharmaceutical Revenue Proportion by Application in 2024
Table 58. Hainan Jianke Pharmaceutical Revenue Proportion by Geographic Area in 2024
Table 59. Hainan Jianke Pharmaceutical Gum Swelling and Pain Relief Medicine SWOT Analysis
Table 60. Hainan Jianke Pharmaceutical Recent Developments
Table 61. Shenzhen Nanyue Pharmaceutical Corporation Information
Table 62. Shenzhen Nanyue Pharmaceutical Description and Major Businesses
Table 63. Shenzhen Nanyue Pharmaceutical Product Features and Attributes
Table 64. Shenzhen Nanyue Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Shenzhen Nanyue Pharmaceutical Revenue Proportion by Product in 2024
Table 66. Shenzhen Nanyue Pharmaceutical Revenue Proportion by Application in 2024
Table 67. Shenzhen Nanyue Pharmaceutical Revenue Proportion by Geographic Area in 2024
Table 68. Shenzhen Nanyue Pharmaceutical Gum Swelling and Pain Relief Medicine SWOT Analysis
Table 69. Shenzhen Nanyue Pharmaceutical Recent Developments
Table 70. Jiangsu Chen Brand Bond Pharmaceutical Co., Ltd. Corporation Information
Table 71. Jiangsu Chen Brand Bond Pharmaceutical Co., Ltd. Description and Major Businesses
Table 72. Jiangsu Chen Brand Bond Pharmaceutical Co., Ltd. Product Features and Attributes
Table 73. Jiangsu Chen Brand Bond Pharmaceutical Co., Ltd. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Jiangsu Chen Brand Bond Pharmaceutical Co., Ltd. Revenue Proportion by Product in 2024
Table 75. Jiangsu Chen Brand Bond Pharmaceutical Co., Ltd. Revenue Proportion by Application in 2024
Table 76. Jiangsu Chen Brand Bond Pharmaceutical Co., Ltd. Revenue Proportion by Geographic Area in 2024
Table 77. Jiangsu Chen Brand Bond Pharmaceutical Co., Ltd. Gum Swelling and Pain Relief Medicine SWOT Analysis
Table 78. Jiangsu Chen Brand Bond Pharmaceutical Co., Ltd. Recent Developments
Table 79. Lion Corporation Corporation Information
Table 80. Lion Corporation Description and Major Businesses
Table 81. Lion Corporation Product Features and Attributes
Table 82. Lion Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Lion Corporation Recent Developments
Table 84. GlaxoSmithKline Corporation Information
Table 85. GlaxoSmithKline Description and Major Businesses
Table 86. GlaxoSmithKline Product Features and Attributes
Table 87. GlaxoSmithKline Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. GlaxoSmithKline Recent Developments
Table 89. Harbin Pharmaceutical Group Corporation Information
Table 90. Harbin Pharmaceutical Group Description and Major Businesses
Table 91. Harbin Pharmaceutical Group Product Features and Attributes
Table 92. Harbin Pharmaceutical Group Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Harbin Pharmaceutical Group Recent Developments
Table 94. YANGTZE River Pharmaceutical Group Corporation Information
Table 95. YANGTZE River Pharmaceutical Group Description and Major Businesses
Table 96. YANGTZE River Pharmaceutical Group Product Features and Attributes
Table 97. YANGTZE River Pharmaceutical Group Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. YANGTZE River Pharmaceutical Group Recent Developments
Table 99. Raw Materials Key Suppliers
Table 100. Distributors List
Table 101. Market Trends and Market Evolution
Table 102. Market Drivers and Opportunities
Table 103. Market Challenges, Risks, and Restraints
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Gum Swelling and Pain Relief Medicine Product Picture
Figure 2. Global Gum Swelling and Pain Relief Medicine Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Amoxicillin Product Picture
Figure 4. Cephalosporins Product Picture
Figure 5. Ornidazole Product Picture
Figure 6. Others Product Picture
Figure 7. Global Gum Swelling and Pain Relief Medicine Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Hospital
Figure 9. Pharmacy
Figure 10. Others
Figure 11. Gum Swelling and Pain Relief Medicine Report Years Considered
Figure 12. Global Gum Swelling and Pain Relief Medicine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Gum Swelling and Pain Relief Medicine Revenue (2020-2031) & (US$ Million)
Figure 14. Global Gum Swelling and Pain Relief Medicine Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Gum Swelling and Pain Relief Medicine Revenue Market Share by Region (2020-2031)
Figure 16. Global Gum Swelling and Pain Relief Medicine Revenue Market Share Ranking (2024)
Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 18. Amoxicillin Revenue Market Share by Player in 2024
Figure 19. Cephalosporins Revenue Market Share by Player in 2024
Figure 20. Ornidazole Revenue Market Share by Player in 2024
Figure 21. Others Revenue Market Share by Player in 2024
Figure 22. Global Gum Swelling and Pain Relief Medicine Revenue Market Share by Type (2020-2031)
Figure 23. Global Gum Swelling and Pain Relief Medicine Revenue Market Share by Application (2020-2031)
Figure 24. North America Gum Swelling and Pain Relief Medicine Revenue YoY (2020-2031) & (US$ Million)
Figure 25. North America Top 5 Players Gum Swelling and Pain Relief Medicine Revenue (US$ Million) in 2024
Figure 26. North America Gum Swelling and Pain Relief Medicine Revenue (US$ Million) by Type (2020 - 2031)
Figure 27. North America Gum Swelling and Pain Relief Medicine Revenue (US$ Million) by Application (2020-2031)
Figure 28. US Gum Swelling and Pain Relief Medicine Revenue (2020-2031) & (US$ Million)
Figure 29. Canada Gum Swelling and Pain Relief Medicine Revenue (2020-2031) & (US$ Million)
Figure 30. Mexico Gum Swelling and Pain Relief Medicine Revenue (2020-2031) & (US$ Million)
Figure 31. Europe Gum Swelling and Pain Relief Medicine Revenue YoY (2020-2031) & (US$ Million)
Figure 32. Europe Top 5 Players Gum Swelling and Pain Relief Medicine Revenue (US$ Million) in 2024
Figure 33. Europe Gum Swelling and Pain Relief Medicine Revenue (US$ Million) by Type (2020-2031)
Figure 34. Europe Gum Swelling and Pain Relief Medicine Revenue (US$ Million) by Application (2020-2031)
Figure 35. Germany Gum Swelling and Pain Relief Medicine Revenue (2020-2031) & (US$ Million)
Figure 36. France Gum Swelling and Pain Relief Medicine Revenue (2020-2031) & (US$ Million)
Figure 37. U.K. Gum Swelling and Pain Relief Medicine Revenue (2020-2031) & (US$ Million)
Figure 38. Italy Gum Swelling and Pain Relief Medicine Revenue (2020-2031) & (US$ Million)
Figure 39. Russia Gum Swelling and Pain Relief Medicine Revenue (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Gum Swelling and Pain Relief Medicine Revenue YoY (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific Top 8 Players Gum Swelling and Pain Relief Medicine Revenue (US$ Million) in 2024
Figure 42. Asia-Pacific Gum Swelling and Pain Relief Medicine Revenue (US$ Million) by Type (2020-2031)
Figure 43. Asia-Pacific Gum Swelling and Pain Relief Medicine Revenue (US$ Million) by Application (2020-2031)
Figure 44. Indonesia Gum Swelling and Pain Relief Medicine Revenue (2020-2031) & (US$ Million)
Figure 45. Japan Gum Swelling and Pain Relief Medicine Revenue (2020-2031) & (US$ Million)
Figure 46. South Korea Gum Swelling and Pain Relief Medicine Revenue (2020-2031) & (US$ Million)
Figure 47. Australia Gum Swelling and Pain Relief Medicine Revenue (2020-2031) & (US$ Million)
Figure 48. India Gum Swelling and Pain Relief Medicine Revenue (2020-2031) & (US$ Million)
Figure 49. Indonesia Gum Swelling and Pain Relief Medicine Revenue (2020-2031) & (US$ Million)
Figure 50. Vietnam Gum Swelling and Pain Relief Medicine Revenue (2020-2031) & (US$ Million)
Figure 51. Malaysia Gum Swelling and Pain Relief Medicine Revenue (2020-2031) & (US$ Million)
Figure 52. Philippines Gum Swelling and Pain Relief Medicine Revenue (2020-2031) & (US$ Million)
Figure 53. Singapore Gum Swelling and Pain Relief Medicine Revenue (2020-2031) & (US$ Million)
Figure 54. Central and South America Gum Swelling and Pain Relief Medicine Revenue YoY (2020-2031) & (US$ Million)
Figure 55. Central and South America Top 5 Players Gum Swelling and Pain Relief Medicine Revenue (US$ Million) in 2024
Figure 56. Central and South America Gum Swelling and Pain Relief Medicine Revenue (US$ Million) by Type (2020-2031)
Figure 57. Central and South America Gum Swelling and Pain Relief Medicine Revenue (US$ Million) by Application (2020-2031)
Figure 58. Brazil Gum Swelling and Pain Relief Medicine Revenue (2020-2025) & (US$ Million)
Figure 59. Argentina Gum Swelling and Pain Relief Medicine Revenue (2020-2025) & (US$ Million)
Figure 60. Middle East and Africa Gum Swelling and Pain Relief Medicine Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Middle East and Africa Top 5 Players Gum Swelling and Pain Relief Medicine Revenue (US$ Million) in 2024
Figure 62. South America Gum Swelling and Pain Relief Medicine Revenue (US$ Million) by Type (2020-2031)
Figure 63. Middle East and Africa Gum Swelling and Pain Relief Medicine Revenue (US$ Million) by Application (2020-2031)
Figure 64. GCC Countries Gum Swelling and Pain Relief Medicine Revenue (2020-2025) & (US$ Million)
Figure 65. Israel Gum Swelling and Pain Relief Medicine Revenue (2020-2025) & (US$ Million)
Figure 66. Egypt Gum Swelling and Pain Relief Medicine Revenue (2020-2025) & (US$ Million)
Figure 67. South Africa Gum Swelling and Pain Relief Medicine Revenue (2020-2025) & (US$ Million)
Figure 68. Gum Swelling and Pain Relief Medicine Industry Chain Mapping
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
